FibroScan®
Communiqué de presse | 19.01.2022
Blog et actualités
topic :
category :
statut :
Article | 19.01.2022
Liver Health Experts and Echosens Technology Featured on eHealth Radio Network
Webinar | 19.01.2022
AASLD Wrap Up; Key Lessons in NAFLD NASH Diagnostic Strategies
Article | 19.01.2022
Highlights from 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan® Mitigates Risk of Patients Developing Fibrosis/Cirrhosis
Article | 19.01.2022
Non-Invasive Point-of-Care Exam Helps Battle Liver Disease in Individuals with Obesity
Article | 19.01.2022
Link Between Non-alcoholic Fatty Liver Disease, Obesity and Liver Cancer Calls for Early Detection and Monitoring
Article | 19.01.2022
New EASL Clinical Practice Guidelines Make Unprecedented Recommendation for Non-Invasive FibroScan® and Care Management
Communiqué de presse | 19.01.2022
Echosens Highlights New EASL Clinical Practice Guidelines
Article | 19.01.2022
Douglas Dieterich, M.D., discusses role of FibroScan® in the diagnoses of chronic liver disease
Article | 19.01.2022
Non-Invasive Liver Exam Identifies Asymptomatic Liver Disease, Provides Follow-Up for Hepatitis C Virus
Article | 19.01.2022
NICE Experts Endorse FibroScan®: Cost-Effective Liver Exam
Article | 19.01.2022
Lancet Study: FibroScan® Identifies Severe Fibrosis/Cirrhosis for Earlier Diagnosis
Webinar | 19.01.2022
Enhancing the management of NAFLD patients with FibroScan®-based scores
Communiqué de presse | 19.01.2022
Leading Liver Disease Researchers Present at EASL International Liver Congress™ 2021
Article | 19.01.2022